Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

NCT00145431 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipoproteinemia Type III

Interventions

DRUG: torcetrapib/atorvastatin
DRUG: atorvastatin
DRUG: fenofibrate

Sponsor

Pfizer